Sunshine Biopharma (SBFMW) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFMW) Net Income towards Common Stockholders Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 33.22% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 2.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 4.50% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 66.11% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -17.90% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -30.70% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 253.53% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 96.66% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 9.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.93% |
| Dec 31, 2025 | 55.01% |
| Sep 30, 2025 | 30.12% |
| Jun 30, 2025 | -76.26% |
| Mar 31, 2025 | 1.55% |
| Dec 31, 2024 | -73.64% |
| Sep 30, 2024 | 33.32% |
| Jun 30, 2024 | 14.84% |
| Mar 31, 2024 | 40.79% |
| Sep 30, 2022 | -783.60% |
| Jun 30, 2022 | -534.26% |
| Mar 31, 2022 | -736.51% |
| Dec 31, 2021 | 318.50% |
| Sep 30, 2021 | -815.50% |
| Jun 30, 2021 | -711.24% |
| Mar 31, 2021 | -194.50% |
| Sep 30, 2019 | 74.55% |
| Jun 30, 2019 | 83.63% |
| Mar 31, 2019 | 69.79% |
| Dec 31, 2018 | 72.13% |